Hematoloxía
Servicio
Hospital Universitario de Guadalajara
Guadalajara, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Guadalajara (11)
2024
-
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice
Blood, Vol. 144, Núm. 6, pp. 646-656
2023
-
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry
Cancer Medicine, Vol. 12, Núm. 14, pp. 14892-14901
2022
2021
-
Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura
Journal of Clinical Apheresis, Vol. 36, Núm. 4, pp. 563-573
-
Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project
Haemophilia, Vol. 27, Núm. 6, pp. 1007-1021
2020
-
Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort
Thrombosis and Haemostasis, Vol. 120, Núm. 3, pp. 437-448
2019
-
Identification of 58 mutations (26 Novel) in 94 of 109 symptomatic Spanish probands with protein C deficiency
Thrombosis and Haemostasis, Vol. 119, Núm. 9, pp. 1409-1418
-
Unraveling the effect of silent, intronic and missense mutations on VWF splicing: Contribution of next generation sequencing in the study of mRNA
Haematologica, Vol. 104, Núm. 3, pp. 587-598
2018
2017
-
Molecular and clinical profile of von willebrand disease in Spain (PCM-EVW-ES): Comprehensive genetic analysis by next-generation sequencing of 480 patients
Haematologica, Vol. 102, Núm. 12, pp. 2005-2014
2016
-
Molecular and clinical profile of von willebrand disease in spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm
Thrombosis and Haemostasis, Vol. 115, Núm. 1, pp. 40-50